Roche Holding AG (RHHBF)
428.24
-5.77
(-1.33%)
USD |
OTCM |
Sep 16, 16:00
Roche Price : 428.24 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | 429.85 | 429.85 | 428.24 | 428.24 | 9.000 |
| Sep 15, 2026 | 434.01 | 434.01 | 434.01 | 434.01 | 166.00 |
| Sep 14, 2026 | 434.01 | 434.01 | 434.01 | 434.01 | 5.000 |
| Sep 11, 2026 | 433.00 | 433.00 | 433.00 | 433.00 | 0.000 |
| Sep 10, 2026 | 436.00 | 436.00 | 433.00 | 433.00 | 22.00 |
| Sep 09, 2026 | 450.00 | 450.00 | 450.00 | 450.00 | 13.00 |
| Sep 08, 2026 | 450.00 | 450.00 | 450.00 | 450.00 | 30.00 |
| Sep 04, 2026 | 441.39 | 441.39 | 441.39 | 441.39 | 0.000 |
| Sep 03, 2026 | 441.39 | 441.39 | 441.39 | 441.39 | 0.000 |
| Sep 02, 2026 | 436.50 | 441.68 | 436.50 | 441.39 | 66.00 |
| Sep 01, 2026 | 440.00 | 440.00 | 436.00 | 436.50 | 19.00 |
| Aug 31, 2026 | 454.00 | 454.00 | 453.78 | 453.78 | 33.00 |
| Aug 28, 2026 | 456.52 | 456.52 | 456.52 | 456.52 | 1.000 |
| Aug 27, 2026 | 474.80 | 475.00 | 460.97 | 460.97 | 93.00 |
| Aug 26, 2026 | 468.00 | 471.84 | 467.00 | 467.00 | 28.00 |
| Aug 25, 2026 | 471.50 | 480.00 | 471.50 | 480.00 | 36.00 |
| Aug 24, 2026 | 468.10 | 468.10 | 468.10 | 468.10 | 0.000 |
| Aug 21, 2026 | 471.50 | 471.50 | 468.10 | 468.10 | 12.00 |
| Aug 20, 2026 | 470.00 | 470.00 | 465.00 | 465.00 | 72.00 |
| Aug 19, 2026 | 460.00 | 460.00 | 459.47 | 459.47 | 11.00 |
| Aug 18, 2026 | 456.87 | 457.42 | 440.00 | 440.00 | 57.00 |
| Aug 17, 2026 | 470.75 | 470.75 | 447.54 | 447.54 | 111.00 |
| Aug 14, 2026 | 422.83 | 443.68 | 422.83 | 443.68 | 36.00 |
| Aug 13, 2026 | 455.88 | 455.88 | 455.88 | 455.88 | 0.000 |
| Aug 12, 2026 | 455.88 | 455.88 | 455.88 | 455.88 | 1.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novartis AG | 140.94 |
| GSK Plc | 51.07 |
| Merck & Co., Inc. | 147.16 |
| Pfizer Inc. | 27.63 |
| Addex Therapeutics Ltd. | 3.36 |
Price Related Metrics
| PE Ratio | 22.15 |
| PS Ratio | 4.488 |
| PEG Ratio | 0.7429 |
| Price to Free Cash Flow | 21.06 |
| Earnings Yield | 4.52% |
| Market Cap | 341.21B |
| PEGY Ratio | 0.6708 |
| Operating PE Ratio | 14.64 |
| Normalized PE Ratio | 18.56 |